What is the most effective eyedrop for allergic conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For allergic eye symptoms, I strongly recommend using dual-action agent eye drops, such as olopatadine (Pataday, Patanol) or ketotifen (Alaway, Zaditor), as they have been shown to be more effective in preventing or treating ocular itching than other ocular agents 1. These medications combine antihistamine and mast cell stabilizer activities, providing quick relief from itching, redness, and tearing, with an onset of action within 30 minutes. Key benefits of these dual-action agents include:

  • Fast onset of action
  • Effective for both acute and longer-term treatment of allergic conjunctivitis symptoms
  • Suitable for prophylactic use during allergy season or when exposed to known triggers
  • Generally well-tolerated with minimal side effects When using these eye drops, it is essential to:
  • Use 1-2 drops in each affected eye, typically once or twice daily depending on the specific product
  • Remove contact lenses before applying the drops and wait 10-15 minutes before reinserting
  • Apply consistently during allergy season or when exposed to known triggers for best results If over-the-counter options do not provide relief after 1-2 weeks of consistent use, prescription-strength options like Pazeo (olopatadine 0.7%) or steroid eye drops may be necessary through a doctor, as they can provide additional relief for more severe symptoms 1.

From the FDA Drug Label

Loteprednol Etabonate Ophthalmic Suspension, 0.2% is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. In two double-masked, placebo-controlled six-week environmental studies of 268 patients with seasonal allergic conjunctivitis, Loteprednol Etabonate Ophthalmic Suspension, 0. 2%, when dosed four times per day was superior to placebo in the treatment of the signs and symptoms of seasonal allergic conjunctivitis.

The best eyedrop for allergies is Loteprednol Etabonate Ophthalmic Suspension, 0.2% 2, as it is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis 2. It has been shown to provide reduction in bulbar conjunctival injection and itching, beginning approximately 2 hours after instillation of the first dose and throughout the first 14 days of treatment. Key benefits include:

  • Temporary relief of signs and symptoms of seasonal allergic conjunctivitis
  • Reduction in bulbar conjunctival injection and itching
  • Superior to placebo in treatment of seasonal allergic conjunctivitis 2

From the Research

Best Eyedrop for Allergies

  • The most effective eyedrop for allergies depends on various factors, including the type and severity of the allergy, as well as individual patient responses to different medications.
  • Studies have compared the efficacy of various topical antihistamines and mast cell stabilizers, including ketotifen fumarate, olopatadine HCl, epinastine, azelastine, and alcaftadine 3, 4, 5, 6, 7.
  • Olopatadine has been shown to be effective in reducing the expression of cell adhesion molecules and inflammatory markers in conjunctival surface cells, and has been found to be superior to other topical anti-allergic medications in some studies 3, 5, 7.
  • Epinastine has also been found to be effective in treating allergic conjunctivitis, and has been shown to be more comfortable than azelastine and ketotifen in a short-term study 6.
  • High-concentration olopatadine (0.77%) has been found to have a longer duration of action and better efficacy on ocular itch compared to low-concentration olopatadine (0.1%) 4.

Comparison of Eyedrops

  • A study comparing ketotifen fumarate 0.025% and olopatadine HCl 0.1% found that both medications were effective in treating seasonal allergic conjunctivitis, but that ketotifen may have a more pronounced effect on reducing the expression of cell adhesion molecules and inflammatory markers 3.
  • Another study found that olopatadine 0.1% was more effective than ketotifen in reducing ocular itch and conjunctival hyperemia 4.
  • A review of clinical studies found that olopatadine was superior to other topical anti-allergic medications, including mast cell stabilizers and antihistamines, in treating allergic conjunctivitis 5, 7.

Patient Comfort and Tolerability

  • A study comparing the comfort and drying effects of epinastine, azelastine, and ketotifen found that epinastine was rated as more comfortable than azelastine and ketotifen, and that none of the medications were associated with significant acute ocular drying effects 6.
  • Olopatadine has been found to be well-tolerated and effective in reducing the symptoms of allergic conjunctivitis, with a low incidence of adverse events 3, 5, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.